CardioExchange Archive

November 1st, 2013

Hip and Knee Replacements Associated with Lower CV Risk

Total joint arthroplasty was associated with reduced cardiovascular risk among patients with knee or hip osteoarthritis in a BMJ study. Researchers in Canada matched roughly 150 people aged 55 or older with moderate-to-severe knee or hip osteoarthritis who underwent total joint replacement to people with osteoarthritis who did not have surgery. People who underwent arthroplasty were less […]

---

June 10th, 2013

Selections from Richard Lehman’s Literature Review: June 10th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include controlling diabetes through surgery or medical management, the risk for diabetes among those taking statins, and aspirin vs. low-molecular-weight heparin for extended VTE prophlyaxis after total hip replacement.

---

September 17th, 2012

Selections from Richard Lehman’s Literature Review: September 17th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include surgical vs. lifestyle treatment for type-2 diabetes, omega-3 fatty-acid supplementation and the risk for major CVD events, FAME 2, using high-sensitivity cardiac troponin T for one-hour rule-out or rule-in of acute MI, and the timing of acute MI in patients having total hip or knee replacement.

---

July 23rd, 2012

Elevated Risk for Acute MI After Total-Hip or -Knee Replacement Surgery

Larry Husten, PHD

A large study reports a high increased risk for acute MI (AMI) in the first 6 weeks after total-hip replacement (THR) or total-knee replacement (TKR) surgery. Analyzing a nationwide cohort from Denmark that included 95,227 patients who underwent THR or TKR and matched controls, Arief Lalmohamed and colleagues calculated the adjusted hazard ratios (HR) for AMI. Their […]

---